IL83687A0 - - Google Patents

Info

Publication number
IL83687A0
IL83687A0 IL83687A IL8368787A IL83687A0 IL 83687 A0 IL83687 A0 IL 83687A0 IL 83687 A IL83687 A IL 83687A IL 8368787 A IL8368787 A IL 8368787A IL 83687 A0 IL83687 A0 IL 83687A0
Authority
IL
Israel
Prior art keywords
receptor
pct
decoyant
retains
sec
Prior art date
Application number
IL83687A
Other languages
English (en)
Other versions
IL83687A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IL8368787A priority Critical patent/IL83687A/en
Publication of IL83687A0 publication Critical patent/IL83687A0/xx
Priority to CA000576111A priority patent/CA1336489C/en
Priority to JP63507516A priority patent/JP2791074B2/ja
Priority to AT88908569T priority patent/ATE123224T1/de
Priority to AU23839/88A priority patent/AU2383988A/en
Priority to US07/410,778 priority patent/US5770572A/en
Priority to PCT/US1988/002991 priority patent/WO1989001779A1/en
Priority to EP88908569A priority patent/EP0329778B1/de
Priority to DE3853910T priority patent/DE3853910T2/de
Priority to FI892005A priority patent/FI100169B/fi
Priority to NO89891787A priority patent/NO891787L/no
Priority to DK198902119A priority patent/DK175596B1/da
Publication of IL83687A publication Critical patent/IL83687A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paper (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Saccharide Compounds (AREA)
  • Polyamides (AREA)
IL8368787A 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions IL83687A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
DE3853910T DE3853910T2 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung.
AU23839/88A AU2383988A (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
JP63507516A JP2791074B2 (ja) 1987-08-30 1988-08-30 分子状デコイアント及びその使用方法
AT88908569T ATE123224T1 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung.
CA000576111A CA1336489C (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
US07/410,778 US5770572A (en) 1987-08-30 1988-08-30 Methods and compositions using molecular decoyants for ameliorating the undesired effects of foreign agents which bind to endogenous receptors
PCT/US1988/002991 WO1989001779A1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
EP88908569A EP0329778B1 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung
FI892005A FI100169B (fi) 1987-08-30 1989-04-27 Menetelmä molekulaarisen syötin valmistamiseksi
NO89891787A NO891787L (no) 1987-08-30 1989-04-28 Molekylaere lokkemidler og fremgangsmaate for anvendelse derav.
DK198902119A DK175596B1 (da) 1987-08-30 1989-05-01 Molekylfælde og anvendelse deraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions

Publications (2)

Publication Number Publication Date
IL83687A0 true IL83687A0 (de) 1988-01-31
IL83687A IL83687A (en) 1995-03-30

Family

ID=11058121

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions

Country Status (12)

Country Link
US (1) US5770572A (de)
EP (1) EP0329778B1 (de)
JP (1) JP2791074B2 (de)
AT (1) ATE123224T1 (de)
AU (1) AU2383988A (de)
CA (1) CA1336489C (de)
DE (1) DE3853910T2 (de)
DK (1) DK175596B1 (de)
FI (1) FI100169B (de)
IL (1) IL83687A (de)
NO (1) NO891787L (de)
WO (1) WO1989001779A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347435A4 (en) * 1987-09-04 1991-11-21 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
US5132402A (en) * 1987-11-25 1992-07-21 Agency Of Industrial Science And Technology Adsorbent, method for production thereof, and method for use thereof
EP0318240A3 (de) * 1987-11-25 1990-08-16 AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY Peptidadsorbens, Methode zu dessen Herstellung und dessen Verwendung
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
US8535672B2 (en) * 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
AU2003256381A1 (en) * 2002-07-03 2004-01-23 Pericor Science, Inc Compositions of hyaluronic acid and methods of use
JP4495776B1 (ja) * 2009-07-30 2010-07-07 日本製薬株式会社 融合蛋白質
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US20150275231A1 (en) * 2014-03-31 2015-10-01 Mice With Horns, Llc Method of Preventing or Reducing Virus Transmission in Animals
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5126433A (en) * 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4
EP0280710B1 (de) * 1986-08-21 1996-03-20 The Trustees Of Columbia University In The City Of New York Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids

Also Published As

Publication number Publication date
FI892005A0 (fi) 1989-04-27
DK211989A (da) 1989-06-28
DE3853910D1 (de) 1995-07-06
EP0329778A4 (en) 1990-12-27
WO1989001779A1 (en) 1989-03-09
DK211989D0 (da) 1989-05-01
US5770572A (en) 1998-06-23
JPH02502538A (ja) 1990-08-16
EP0329778A1 (de) 1989-08-30
CA1336489C (en) 1995-08-01
FI100169B (fi) 1997-10-15
NO891787L (no) 1989-06-06
JP2791074B2 (ja) 1998-08-27
FI892005A (fi) 1989-04-27
DE3853910T2 (de) 1995-10-12
EP0329778B1 (de) 1995-05-31
ATE123224T1 (de) 1995-06-15
NO891787D0 (no) 1989-04-28
IL83687A (en) 1995-03-30
AU2383988A (en) 1989-03-31
DK175596B1 (da) 2004-12-13

Similar Documents

Publication Publication Date Title
IL83687A0 (de)
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
PT781129E (pt) Preparacao farmaceutica contendo metformina e processo para a sua preparacao
BR9408377A (pt) Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
PT86399A (pt) Processo para a preparacao de hidrossoles de agentes farmacologicamente activos e de composicoes que os contem
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
FI834320A (fi) Peptidfoereningar.
AR011957A1 (es) Derivados de dolastatina 15 con funcionalidades carbonilo y heterociclicas en el c-terminal
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
ATE78162T1 (de) 5-ht3-rezeptor-antagonisten zur behandlung von husten und bronchokonstriktion.
MX14957A (es) Nuevos derivados de tetrazol y procedimiento para su preparacion.
ES8206447A1 (es) Procedimiento para preparar derivados de enterotoxina termoestable (st) de e. coli.
PT94625A (pt) Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
DE69228488D1 (de) Verfahren und zubereitung geeignet als keratin enthaltende diät für tiere
NO884523L (no) Joderte polymerer, fremgangsmaate for deres fremstilling og deres anvendelse som kontrastmidler.
ES2058992T3 (es) Un procedimiento para la preparacion de polipeptido que estimula celulas t.
BR9808424A (pt) Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto.
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
SE8203054L (sv) Antihypertensivt medel
DE3686706D1 (de) Glaukomhemmende zusammensetzungen und verfahren zu ihrer herstellung.
IT1157268B (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
ES2031552T3 (es) 2-selenometil-1,4-dihidropiridinas, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired